Antisense strategies in dopamine receptor pharmacology
- 10 January 1997
- journal article
- review article
- Published by Elsevier BV in Life Sciences
- Vol. 60 (7), 433-455
- https://doi.org/10.1016/s0024-3205(96)00566-8
Abstract
No abstract availableKeywords
This publication has 84 references indexed in Scilit:
- Dopamine receptor blockade increases dopamine D2 receptor and glutamic acid decarboxylase mRNAs in mouse substantia nigraEuropean Journal of Pharmacology: Molecular Pharmacology, 1994
- Low density of dopamine D4 receptors in Parkinson's, schizophrenia, and control brain striataSynapse, 1993
- Irreversible blockade of D2 dopamine receptors by fluphenazine-N-mustard increases glutamic acid decarboxylase mRNA in rat striatumNeuroscience Letters, 1993
- Developmental and age-related changes in the D2 dopamine receptor mRNA subtypes in rat brainNeurochemistry International, 1992
- Rational design of sequence-specific oncogene inhibitors based on antisense and antigene oligonucleotidesEuropean Journal of Cancer and Clinical Oncology, 1991
- Ontogenetic expression of D2 dopamine receptor mRNA in rat corpus striatumDevelopmental Brain Research, 1991
- Molecular biology of the dopamine receptorsEuropean Journal of Pharmacology: Molecular Pharmacology, 1991
- Up-regulation of dopamine D2 receptor mRNA in rat striatum by chronic neuroleptic treatmentEuropean Journal of Pharmacology: Molecular Pharmacology, 1991
- Shorter variants of the D3 dopamine receptor produced through various patterns of alternative splicingBiochemical and Biophysical Research Communications, 1991
- MK-801-induced stereotypy and its antagonism by neuroleptic drugsJournal of Neural Transmission, 1990